NKTX
Looking like a technical reversal on the daily chart - MACD, TTM, and MACD look very resilient after a selloff.
Analysts set price targets at 15$, indicators seem to match up with this. Earnings in 17 days and mid-year treatment trials could be catalysts to move the price towards this target. Earlier results were promising.
Make sure to manage your R:R and size appropriately. Tell me what you think about this setup in the comments.
BW